The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
Open accessAbstract
Resolvins of the D series are generated from docosahexaenoic acid, which are enriched in fish oils and are believed to exert beneficial roles on diverse inflammatory disorders, including inflammatory bowel disease (IBD). In this study, we investigated the anti-inflammatory effects of the aspirin-triggered resolvin D1 (AT-RvD1), its precursor (17(R)-hydroxy docosahexaenoic acid [17R-HDHA]) and resolvin D2 (RvD2) in dextran sulfate sodium (DSS)- or 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Our results showed that the systemic treatment with AT-RvD1, RvD2, or 17R-HDHA in a nanogram range greatly improved disease activity index, body weight loss, colonic damage, and polymorphonuclear infiltration in both colitis experimental models. Moreover, these treatments reduced colonic cytokine levels for TNF-α, IL-1β, MIP-2, and CXCL1/KC, as well as mRNA expression of NF-κB and the adhesion molecules VCAM-1, ICAM-1, and LFA-1. Furthermore, AT-RvD1, but not RvD2 or 17R-HDHA, depended on lipoxin A4 receptor (ALX) activation to inhibit IL-6, MCP-1, IFN-γ, and TNF-α levels in bone marrow-derived macrophages stimulated with LPS. Similarly, ALX blockade reversed the beneficial effects of AT-RvD1 in DSS-induced colitis. To our knowledge, our findings showed for the first time the anti-inflammatory effects of resolvins of the D series and precursor 17R-HDHA in preventing experimental colitis. We also demonstrated the relevant role exerted by ALX activation on proresolving action of AT-RvD1. Moreover, AT-RvD1 showed a higher potency than 17R-HDHA and RvD2 in preventing DSS-induced colitis. The results suggest that these lipid mediators possess a greater efficacy when compared with other currently used IBD therapies, such as monoclonal anti-TNF, and have the potential to be used for treating IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
Hanauer, S. B. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195385.19268.68 · Cited by 968
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 730
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695
Intestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions
Xu, Z.-Z., Zhang, L., Liu, T., Park, J. Y., Berta, T., Yang, R., Serhan, C. N., & Ji, R.-R. (2010) · Nature Medicine · doi:10.1038/nm.2123 · Cited by 591
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Resolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
Dietary modification of inflammation with lipids
Calder, P. C. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2002166 · Cited by 485
Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Calder, P. C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700289 · Cited by 457
Wallace, J. L., MacNaughton, W. K., Morris, G. P., & Beck, P. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90760-9 · Cited by 435
Optimizing anti-TNF treatment in inflammatory bowel disease
Rutgeerts, P., van Assche, G., & Vermeire, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.070 · Cited by 429
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
Neurath, M. F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Büschenfelde, K., Strober, W., & Kollias, G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270722 · Cited by 413
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis
Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., & Kang, J. X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601280103 · Cited by 379
Novel Lipid Mediators Promote Resolution of Acute Inflammation: Impact of Aspirin and Statins
Spite, M., & Serhan, C. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223883 · Cited by 365
Cominelli, F., Nast, C. C., Clark, B. D., Schindler, R., Lierena, R., Eysselein, V. E., Thompson, R. C., & Dinarello, C. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114799 · Cited by 333
n−3 Fatty acid supplements in rheumatoid arthritis
Kremer, J. M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.349s · Cited by 303
Gewirtz, A. T., Collier-Hyams, L. S., Young, A. N., Kucharzik, T., Guilford, W. J., Parkinson, J. F., Williams, I. R., Neish, A. S., & Madara, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5260 · Cited by 256
Ghia, J.-E., Blennerhassett, P., & Collins, S. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32849 · Cited by 233 · cited 1×
“All animals were examined once a day, and the disease activity index (DAI) was assessed as described previously (26, 27).”
MethodVCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis
Sans, M., Panés, J., Ardite, E., Elizalde, J. I., Arce, Y., Elena, M., Palacín, A., Fernández–Checa, J. C., Anderson, D. C., Lobb, R., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70070-3 · Cited by 228
Lima-Garcia, J., Dutra, R., da Silva, K., Motta, E., Campos, M., & Calixto, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01345.x · Cited by 209
Self-citationLipoxins and new lipid mediators in the resolution of inflammation
SCHWAB, J., & SERHAN, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.006 · Cited by 207
Camuesco, D., Gálvez, J., Nieto, A., Comalada, M., Rodríguez-Cabezas, M. E., Concha, A., Xaus, J., & Zarzuelo, A. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.4.687 · Cited by 200
VCAM-1, but Not ICAM-1 or MAdCAM-1, Immunoblockade Ameliorates DSS-Induced Colitis in Mice
Soriano, A., Salas, A., Salas, A., Sans, M., Gironella, M., Elena, M., Anderson, D. C., Piqué, J. M., & Panés, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780164 · Cited by 183
Resolvin D1 protects mice from LPS-induced acute lung injury
Wang, B., Gong, X., Wan, J.-Y., Zhang, L., Zhang, Z., Li, H.-Z., & Min, S. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.04.001 · Cited by 178
Essani, N. A., Fisher, M. A., Farhood, A., Manning, A. M., Smith, W. C., & Jaeschke, H. (1995) · Hepatology · doi:10.1002/hep.1840210623 · Cited by 175
Ishida, T., Yoshida, M., Arita, M., Nishitani, Y., Nishiumi, S., Masuda, A., Mizuno, S., Takagawa, T., Morita, Y., Kutsumi, H., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21029 · Cited by 170
The current future understanding of inflammatory bowel disease
Podolsky, D. K. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0354 · Cited by 158
The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
Bento, A. F., Leite, D. F. P., Claudino, R. F., Hara, D. B., Leal, P. C., & Calixto, J. Β. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408231 · Cited by 142
Self-citationSouza, D. G., Fagundes, C. T., Amaral, F. A., Cisalpino, D., Sousa, L. P., Vieira, A. T., Pinho, V., Nicoli, J. R., Vieira, L. Q., Fierro, I. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8533 · Cited by 139
Rahman, M. M., Bhattacharya, A., & Fernandes, G. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21188 · Cited by 139
Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury
Satake, K., Matsuyama, Y., Kamiya, M., Kawakami, H., Iwata, H., Adachi, K., & Kiuchi, K. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00253-9 · Cited by 130
Kimball, E. S., Wallace, N. H., Schneider, C. R., D’Andrea, M. R., & Hornby, P. J. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00549.x · Cited by 129
Review: the role of omega 3 fatty acids in intestinal inflammation
Teitelbaum, J. E., & Walker, W. A. (2001) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(00)00141-8 · Cited by 125
Marriott, H. M., Ali, F., Read, R. C., Mitchell, T. J., Whyte, M. K. B., & Dockrell, D. H. (2004) · The FASEB Journal · doi:10.1096/fj.03-1450fje · Cited by 119
Camuesco, D., Comalada, M., Concha, Á., Nieto, A., Sierra, S., Xaus, J., Zarzuelo, A., & Gálvez, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.12.009 · Cited by 115
Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma
Barker, J. N., Jones, M. L., Swenson, C. L., Sarma, V. J., Mitra, R. S., Ward, P. A., Johnson, K. J., Fantone, J. C., Dixit, V. M., & Nickoloff, B. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1192 · Cited by 101
Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation
Danese, S., SEMERARO, S., MARINI, M., Roberto, I., Armuzzi, A., Papa, A., & Gasbarrini, A. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.03.013 · Cited by 100
Vitor, C. B., Figueiredo, C. P., Hara, D., Bento, A., Mazzuco, T. L., & Calixto, J. Β. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00271.x · Cited by 96
Self-citationMurine Bone Marrow-Derived Macrophages
Stanley, E. R. (2003) · Humana Press eBooks · doi:10.1385/0-89603-150-0:299 · Cited by 95
Tian, H., Lu, Y., Sherwood, A. M., Hongqian, D., & Hong, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3146 · Cited by 79
Stocker, C. J., Sugars, K. L., Harari, O., Landis, R. C., Morley, B. J., & Haskard, D. O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3309 · Cited by 70
Khalfoun, B., Thibault, G., BARDOS, P., & Lebranchu, Y. (1996) · Transplantation · doi:10.1097/00007890-199612150-00020 · Cited by 64
Cho, J. Y., Chi, S., & Chun, H. S. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000070 · Cited by 57
Distal Proctocolitis and n-3 Polyunsaturated Fatty Acids (n-3 PUFAs): The Mucosal Effect In Situ
Almallah, Z., Ewen, S. W. B., El-Tahir, A., Mowat, N. A. G., BRUNT, P. W., Sinclair, T. S., Heys, S. D., & Eremin, O. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006698728816 · Cited by 50
Rafi, M. M., Yadav, P. N., & Rossi, A. O. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600226 · Cited by 42
Hirafuji, M., Machida, T., Tsunoda, M., Miyamoto, A., & Minami, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704768 · Cited by 35
Hara, D. B., Fernandes, E. S., Campos, M. M., & Calixto, J. Β. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.013 · Cited by 22
Self-citation
Cited by
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Na, Y. R., Stakenborg, M., Seok, S. H., & Matteoli, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0172-4 · Cited by 900
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Lipid Mediators in the Resolution of Inflammation
Serhan, C. N., Chiang, N., Dalli, J., & Levy, B. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016311 · Cited by 544
Metadata
- Authors
- Bento, A. F., Claudino, R. F., Dutra, R. C., Marcon, R., & Calixto, J. B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08
- Volume
- 187
- Issue
- 4
- Pages
- 1957-1969
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2172136108
- Cited by
- 256
- References
- 60
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.